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Objectives: Arthrogenous muscle inhibition (AMI) is thought to contribute to quadriceps weakness in
knee osteoarthritis (OA), but its relationship with structural changes of bone marrow lesions (BMLs),
capsular distension and pain is unclear. This study’s objective was to investigate the factors associated
with AMI in subjects with symptomatic patellofemoral joint OA (PFJOA).
Design: 126 Subjects with predominant PFJOA were assessed for pain by the visual analogue scale (VAS)
for a nominated aggravating activity. Their more symptomatic knee underwent a magnetic resonance
imaging (MRI) scan which was used to assess BMLs and synovitis which were scored using the Whole
Organ MRI score (WORMS). Quadriceps AMI was measured by calculating the activation deﬁcit and
quadriceps strength assessed by isometric maximum voluntary contraction. Multiple linear regressions
were used to assess factors associated with AMI.
Results: We studied 124 subjects [mean age 55.5 (SD 7.5); 57.14% female]. In regression analyses, higher
levels of AMI were signiﬁcantly associated with more severe knee pain and with lower BML score.
Conclusion: Quadriceps AMI in knee OA is associated with severity of knee pain and surprisingly with
lower BML scores.
 2014 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
In patients with knee osteoarthritis (OA), quadriceps weakness
is a common clinical feature which is considered to be an important
determinant of disability and is probably due, in part, to arthrog-
enous muscle inhibition (AMI)1,2. Modulated by both presynaptic
and postsynaptic mechanisms, AMI is a reﬂex inhibition thought to
be elicited by abnormal afferents from a damaged joint resulting in
decreased motor drive to muscles and limiting a muscle’s potential
to generate force1.
Studies on AMI have found it exists in knee OA1e6, in knees with
effusion and pain7, post knee trauma8, and just prior to total knee
arthroplasty for OA9. While triggers for AMI are not fully under-
stood, causative factors could be pain3,6 and structural changes toMichael J. Callaghan, Arthritis
eletal Research, University of
ter.ac.uk (M.J. Callaghan),
.e.hutchinson@warwick.ac.uk
. Felson).
lf of Osteoarthritis Research Societarticular cartilage5. Intriguingly, AMI has been found in knee OA
without pain or effusion, indicating that its causes might be com-
plex1. To our knowledge, there have been no studies in knee OA
examining whether pain severity is related to AMI. Furthermore,
we are aware of no studies assessing whether AMI is related to
structural lesions that can be detected by magnetic resonance im-
aging (MRI) assessments, even though a number of lesions in OA
occur in innervated structures whose pathology might be expected
to affect AMI.
The structures seen on MRI implicated in the genesis of painful
knee OA in cross-sectional and longitudinal studies are bone
marrow lesions (BMLs)10,11 and capsular distension/synovitis12.
BMLs reﬂect areas of bone trauma caused by increased stress; bone
is richly innervated, in contrast to aneural hyaline cartilage. BMLs
are common in moderate to severe OA and may reﬂect a marker of
the severity of OA pathology. Their role in AMI is unknown.
Capsular distension consists of the combination of synovitis and
effusion, both of which are frequently present in OA and correlate
with pain and other clinical outcomes13. A recent study used clin-
ical examination to detect and score knee effusions subsequent to
acute anterior cruciate ligament (ACL) injury but found noy International.
Fig. 1. Diagram of resting twitch (ﬁrst arrow) and superimposed twitch (second
arrow).
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capsular distension on MRIs has not been assessed for this purpose.
The aim of this study was to assess the relationships between
AMI, pain and structural changes of BMLs and capsular distension
on MRI in persons with predominantly patellofemoral joint OA
(PFJOA).
The hypothesis was that quadriceps AMI would be signiﬁcantly
associated with knee pain severity and structural changes. Since
AMI underlies much of the weakness that affects people with knee
OA, identifying factors associatedwith AMImay offer a glimpse into
factors that may alter muscle weakness and its consequences in OA.
Methods
The study was approved by the Central Manchester Local
Research Ethics Committee (LREC) and Wellcome Trust Clinical
Research Facility, Scientiﬁc Advisory Board. Scans and other mea-
sures were performed at the Wellcome Trust CRF, Manchester, UK.
Subjects
Participants were recruited from local primary care centres,
hospital based orthopaedic, rheumatology and physiotherapy
clinics. All participants were part of a larger randomized clinical
trial testing patellofemoral bracing International Standard Rando-
mised Controlled Trial Number (ISRCTN) (50380458) with a pro-
jected sample size of 120. The present study constitutes a
secondary analysis of data collected during that study.
Inclusion criteria
Subjects were included if they were aged between 40 and 70
years, had a KellgreneLawrence (KeL) score grade 2 or 3 in the
patellofemoral joint (PFJ) greater than the KeL score for the tibio-
femoral joint (TFJ) of the same knee15. Subjects had to have PFJ
symptoms such as pain reproduced with stair climbing, kneeling,
prolonged sitting or squatting and lateral or medial patellar facet
tenderness on palpation or a positive patellar compression test.
Pain must have been present daily for the previous 3 months and
above a score of 4 on the visual analogue scale (VAS) for their
nominated aggravating activity.
Exclusion criteria
Subjects were excluded if the predominant symptoms
emanated clinically from the TFJ, from meniscal or ligament injury,
if they had rheumatoid arthritis or other forms of inﬂammatory
arthritis or if they had an intra-articular steroid injection into the
painful knee in the previous month. Because we obtained contrast
enhanced (CE)MRI during this study, patients were excluded if they
had a cochlear implant, metal objects in the body including a joint
prosthesis, a cardiac or neural pacemaker, a hydrocephalus shunt,
an intrauterine contraceptive device or coil, if they had impaired
renal dysfunction or were undergoing renal dialysis.
AMI evaluation
Quadriceps inhibition measurements were performed prior to
MRIs. Isometric single joint extension torque of the lower limb was
measured using an isokinetic dynamometer (Isocom, Isokinetic
Technology, Bingham Industrial Estate, Nottingham, UK). For
percutaneous stimulation of the quadriceps, a High Voltage Stim-
ulator was used (DS7AH Digitimer Ltd., Hertfordshire, England).We
used a single twitch with a pulse duration of 200 ms and a stimulus
amplitude of 100mA. Patients were seated with the hip and knee at90 ﬂexion and with torso, hip, and thigh straps applied. The tibial
pad of the lever arm was placed just proximal to the lateral mal-
leolus. Two electrodes (100 130 mm, Axelgaard Co Ltd., Fallbrook,
CA, USA) were placed at one-third and two-thirds from the distance
between the anterior superior iliac spine and the upper border of
the patella over the muscle bellies of vastus lateralis and vastus
medialis respectively. Prior to data collection, familiarisation of the
stimulation sensation was made with several test stimuli at
approximately 50% of the maximum voluntary contraction (MVC)
which also conﬁrmed correct electrode placement. After a
5 min rest period, the single twitch was triggered by the assessor
manually on the relaxed muscles prior to the MVC (resting twitch
torque e RTT)16. The subject contracted the quadriceps maximally
for the MVC during which another single twitch was delivered to
the muscle when voluntary force reached a plateau on the screen
(interpolated twitch torque e ITT). Each MVC attempt lasted 4e5 s
with a rest of 2min between each attempt with standardised verbal
encouragement and visual feedback from the monitor; they were
asked to grasp the chair handles. Three trials were done and the
data collected were the maximal single peak torque value with
twitch interpolation and also the activation deﬁcit (AD) levels at
100% MVC. AD was calculated from the ratio: AD¼ (ITT/RTT) 100.
This technique has been assessed for reliability in our facility and
has an Intraclass correlation coefﬁcient (ICC2,1) 0.73, standard error
of measurement (SEM) ¼ 3.26% and smallest detectable difference
(SDD)¼ 9.03%17. All measurements were taken by an assessor (MJC)
who was blinded to the MRI results (Fig. 1).
MRI methods for BMLs and capsular distension
Subjects had CE MRIs of their more symptomatic knee using a
1.5 T Philips Gyroscan ACS NT (Philips, Best, NL). The imaging
protocol included sagittal spin-echo proton density- and T2-
weighted images [repetition time (TR), 2200 ms; time to echo
(TE), 20/80 ms] with a slice thickness of 3 mm, a 1 mm interslice
gap, 1 excitation, a ﬁeld of view (FOV) of 11e12 cm, and a matrix of
256  192 pixels; and coronal and axial spin-echo fat-suppressed
proton density- and T2-weighted images (TR 2200 ms; TE 20/
80 ms) with a slice thickness of 3 mm, a 1 mm interslice gap, 1
excitation and with the same FOV and matrix.
Intravenous gadolinium (Doteram, Gadoteric Acid, Guerbet Ltd.,
Solihull, UK) was administered at a dose of 0.2 ml (0.1 mmol) kg
body weight. Two minutes after completing the injection of the
gadolinium, sagittal sequences were obtained immediately fol-
lowed by the axial sequences.
BMLs were assessed by the Whole Organ MRI score (WORMS)18
i.e., BMLs in the subarticular marrow were deﬁned as poorly
marginated areas of increased signal intensity in the normally
Table I
Descriptive statistics of the study sample
Statistic Mean (SD) N
Age (years) 55.5 (7.5) 126
BMI (kg/m2) 30.95 (5.75) 126
Females, frequency (%) 72 (57.14) 126
AMI (%) 31.11 (17.06) 125
Maximum voluntary contraction (MVC, Nm) 109.17 (55.39) 125
KOOS pain subscale score (0e100) 49.6 (18.4) 126
Pain on nominated activity VAS (0e10) 65.4 (21.2) 125
Pain in last week VAS (0e10) 58.9 (24.7) 125
BML score e total score 6.03 (4.15) 126
BML score e maximal score from any region* 2.39 (0.74) 126
Capsular distension score 1.41 (1.02) 126
Scoring for KOOS pain subscale: 100 (no pain) to 0 (extreme pain). Scoring for the
VAS: 0 (no pain) to 10 (extreme pain).
* Each region was scored 0 (no BMLs) to 4 (BMLs in 75% of the region).
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and were graded in each region from 0 to 3 based on the extent of
regional involvement; 0¼ none; 1< 25% of the region; 2¼ 25e50%
of the region; 3  50% of the region. We used the sagittal post-
contrast scan and the axial scan to score BML’s. To obtain a re-
gion’s BML score, we summed all BML scores within the region
including all sub-regions. For example for the patellofemoral re-
gion, we summed BML scores for patella and trochlea.
Capsular distension was scored using the semi-quantitative
WORMS system on an ordinal scale 0e318. Scoring was per-
formed by a musculoskeletal radiologist (CEH) with greater than 10
years’ experience in standardised semi-quantitative assessment of
knee OA who was blinded to the AMI and pain values. We used the
sagittal scan to score capsular distension; reliability for these
measures was ICC1,2 ¼ 0.81, SEM ¼ 1.70.
Pain
Pain severity was assessed by a 10 cm VAS (0 ¼ no pain and
10¼worst pain) based on the degree of knee pain they experienced
during a nominated aggravating activity. As a secondary measure,
we also administered the knee injury and osteoarthritis outcome
score (KOOS)19.
Statistical analyses
Analyses were performed using the STATA (version 11.2; STATA
Corporation, College station, TX, USA). Linear regression was used
to explore the bivariate relationships between AMI, pain and MRI
structural change scores in the patellofemoral and tibiofemoral
regions combined.
Following this, multiple linear regressions were performed to
assess which factors among BMLs, capsular distension and painwere
associated with AMI whilst using age, gender, and body mass indexTable II
Association of demographics, knee structural factors and pain with AMI. Total BML score
AMI Bivariate models (no covariates) Mode
b (95% CI) P Model R2 b (95
Unstandardised coefﬁcients
Age 0.47 (0.87 to 0.08) 0.02 0.04
Sex (female) 4.82 (11.03 to 1.39) 0.13 0.02
BMI 1 (0.47 to 1.52) <0.001 0.11
Pain on nominated activity VAS 1.98 (0.77 to 3.19) 0.002 0.06 1.57
Capsular distension 3.05 (6.03 to 0.06) 0.05 0.03 2.77
Total BML score 1.27 (1.85 to 0.69) <0.001 0.10 0.9
All models have been run using robust standard errors, due to heteroscedasticity in mod
* Fully adjusted model indicates adjusted for: age, sex, BMI, and other structural para(BMI) as covariates; these factors have been found to relate to both
BMLs and AMI, and are therefore potential confounders20e22. Initial
inspection of the model residuals showed substantial hetero-
skedasticity, therefore all conﬁdence intervals and P-values presented
were analysed using Huber23 and White24 robust standard errors.Results
One hundred and twenty six patientswere recruited all of whom
obtained MRIs. Table I depicts descriptive statistics for the investi-
gated sample. One patient had a BML score of zero in their affected
knee, with the whole sample having a mean BML score of 6.03 (SD
4.15). During the MVC and twitch interpolation tests, subjects
experienced no increase in pain and reported that their ability to
attempt and maintain a maximal quadriceps contraction was not
affected. One patient was unable to complete the muscle tests for
technical reasons but completed the MRI scans, and also provided
pain scores. One patient did not complete their ‘nominated activity’
VAS. Neither of these patients was included in analyses evaluating
the correlates of AMI, giving a ﬁnal sample size of 124.
Analyses on the relationships between AMI and pain, AMI and
BMLs and AMI and capsular distension are shown in Tables II and III.
We found an association of VAS pain severity with AMI in the
bivariate analysis. This association, although diminished in
magnitude, held when covariates were added in the fully adjusted
model. BMI was also positively associated with AMI, with an in-
crease in BMI. However, BML score on MRI was inversely associated
with AMI; the higher the knee BML score, the less the inhibition.
Capsular distension was also inversely related to AMI in bivariate
analysis but was unrelated to AMI in multivariable analyses.
Overall, results were similar when we repeated the analysis using
KOOS pain as the outcome in all models instead of the VAS pain.Discussion
This study aimed to investigate if knee pain or structural
changes on MRI were associated with quadriceps inhibition in pa-
tients with PFJOA. We found that pain measured by a nominated
activity VAS was associated with AMI, and the magnitude of asso-
ciation was similar when controlling for age, BMI, and gender. The
WORMS BML score was inversely associated with AMI, and this
association, whilst diminished slightly in magnitude, still held
when controlling for the same covariates. Thus our hypothesis was
only partially retained.
Previous studies of AMI compared symptomatic OAwith healthy
asymptomatic subjects, so it is unclear whether it was pain alone or
other disease related factors that were associated with the AMI3,6.
We found a signiﬁcant positive relationship between AMI and pain
for subjects’ nominated aggravating activity, and this suggests it is
pain which plays a role, not necessarily some element of structuralls adjusted for age, sex, and BMI Fully adjusted model*
% CI) P Model R2 b (95% CI) P Model R2
N/A 0.22 (0.60 to 0.16) 0.25 0.26
N/A 7.30 (12.94 to 1.66) 0.01
N/A 0.79 (0.28 to 1.30) 0.003
(0.34 to 2.8) 0.01 0.21 1.49 (0.21 to 2.76) 0.02
(5.89 to 0.35) 0.08 0.20 1.28 (4.42 to 1.86) 0.42
(1.54 to 0.26) 0.01 0.22 0.79 (1.41 to 0.18) 0.01
el residuals.
meters e capsular distension, total WORMS score.
Table III
Association of demographics, knee structural factors and pain with AMI. Maximal BML score from any region
AMI Bivariate models (no covariates) Models adjusted for age, sex, and BMI Fully adjusted model*
b (95% CI) P Model R2 b (95% CI) P Model R2 b (95% CI) P Model R2
Unstandardised coefﬁcients
Age 0.47 (0.87 to 0.08) 0.02 0.04 N/A 0.31 (0.68 to 0.07) 0.11 0.25
Sex (female) 4.82 (11.03 to 1.39) 0.13 0.02 N/A 6.92 (12.55 to 1.29) 0.02
BMI 1 (0.47 to 1.52) <0.001 0.11 N/A 0.77 (0.22 to 1.32) 0.01
Pain on nominated activity VAS 1.98 (0.77 to 3.19) 0.002 0.06 1.57 (0.34 to 2.8) 0.01 0.21 1.37 (0.04 to 2.71) 0.04
Capsular distension 3.05 (6.03 to 0.06) 0.05 0.03 2.77 (5.89 to 0.35) 0.08 0.20 1.2 (4.78 to 2.39) 0.51
Maximal BML score (all areas) 7.22 (10.94 to 3.51) <0.001 0.10 4.83 (8.83 to 0.83) 0.02 0.22 3.74 (8.5 to 1.02) 0.12
All models have been run using robust standard errors, due to heteroscedasticity in model residuals.
* Fully adjusted model indicates adjusted for: age, sex, BMI, and other structural parameters e capsular distension, total WORMS score.
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associated with an increase in AMI of 1.6%.
A key question is why pain severity during nominated aggra-
vating activities was correlated with AMI even though subjects
reported no pain with muscle testing and did not perform the
nominated activity during any part of the examination. Although
AMI is an involuntary increase in muscle contraction after volun-
tary contraction has occurred, it is ultimately dependent on the
amount of voluntary contraction and this may be determined in
part by pain that has been experienced. While pain during the
testing procedure did not compromise effort, Hassan et al.25 noted
that AMI decreased and voluntary contraction increased after
instillation of bupivacaine in OA knees suggesting that eliminating
discomfort improves muscle function. Also, with chronic OA knee
pain, patients are fearful of activities (typically stair ascent, or
descent, kneeling, and squatting) which they know are likely to
increase their pain (kinesiophobia). In contrast, the testing proce-
dure for MVC and AMI did not involve weight bearing with the
subject contracting the quadriceps and performing isometric
extension with the knee in a stable and controlled position.
In terms of structural change and AMI, ﬁrstly we found a
negative correlation between AMI and the BML score in the knee
when measured by WORMS; an increase of just under 1 point on
the total BML score reﬂected a 1 point decrease in AMI using the
coefﬁcient from the fully adjusted model. Secondly, we found no
association between capsular distension and AMI in adjusted ana-
lyses. Studies testing associations between AMI and structural
changes in OA have been limited because the structure of interest,
cartilage, is not innervated. With these limitations, patients with
cartilage damage were found to suffer from a signiﬁcant loss of
activation of the quadriceps muscle compared to those without
damage. MRI has the advantages of visualising the bone marrow
and the synovium, which are both innervated structures where
pathology is related to pain.
Hurley and Newham1,2 showed that AMI was present in OA
knees which at the time of testing did not have a clinical effusion.
This suggested that the cause of AMI was likely due to a complex
relationship between pain, joint structure damage, and muscle
weakness. Lynch et al.14 also reported that clinically assessed effu-
sionwas not associatedwith AMI in any iteration of their regression
models. Thus, our ﬁnding that capsular distension on MRI was not
associated with AMI corroborates these previous ﬁndings.
Our ﬁnding of an inverse relationship between increased
structural damage and decreased AMI has also been observed in
subjects with intraoperative visible knee medial compartment
cartilage damage5. They found the worse the cartilage damage, the
greater the quadriceps activation. One explanation is that the
increased quadriceps voluntary activation might be a compensa-
tion mechanism maintaining muscle function to counter the pro-
gression of OA joint damage.Since BMLs can trigger nociceptive and presumably spinal level
reﬂex arcs, it is conceivable thatmore andbigger BMLsprovidemore
spinal level feedback which might overcome muscle inhibition
signalled by AMI. However, it seems as likely that this is a chance
ﬁnding that may not be replicated in other studies.
The percentage AMI measured in our patients averaged 31%;
that is to say only 69% of quadriceps activation was present during
MVC. Previous work in our facility established a normative AD
value of 8.8% (SD 6.1) meaning that any activation level above 91.2%
could be classed as within normal limits. Lynch et al.14 operationally
deﬁned an activation value of 95% or higher as normal and found
less than 95% activation in 41% of effused knees after ACL rupture.
All but 27 patients in our study with predominant PFJOA had ef-
fusions on MRI. Other studies have included combined TFJ and
PFJOA1,5,25, or assessedmedial knee OA only4.We sought not only to
sub-classify PFJOA from TFJ OA to ensure that our subjects had
predominantly PFJOA but also to visualize BMLs in all compart-
ments of the knee using MRIs.
Our study has some limitations. Firstly, as our focus was on
PFJOA patients our results may have been different had we studied
a more diverse OA population. Secondly, although AMI testing was
performed using standardized, reliable single joint testing pro-
cedures, these do not reﬂect daily function and activity.
Other limitations are that this was a cross-sectional rather than
longitudinal design with no asymptomatic healthy control group
with which to compare. We did not obtain bilateral measurements
for MVC and AMI due to the already lengthy testing protocol. We
used un-potentiated resting twitch and so the activation deﬁcits
might be overestimated.
In summary, AMI in persons with patellofemoral knee OA was
associated with the severity of reported knee pain, with higher BMI
and was inversely associated with the sum of scores of BMLs and
capsular distension in the knee.Authors’ contributions
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